Title: Sumatriptan
CAS Registry Number: 103628-46-2
CAS Name: 3-[2-(Dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulfonamide
Manufacturers' Codes: GR-43175
Molecular Formula: C14H21N3O2S
Molecular Weight: 295.40
Percent Composition: C 56.92%, H 7.17%, N 14.22%, O 10.83%, S 10.85%
Literature References: Serotonin 5HT1-receptor agonist. Prepn: M. D. Dowle, I. H. Coates, DE 3320521; eidem, US 4816470; A. W. Oxford, GB 2162522 (1983, 1989, 1986 all to Glaxo). Receptor binding studies: P. P. A. Humphrey et al., Br. J. Pharmacol. 94, 1123 (1988); P. Schoeffter, D. Hoyer, Arch. Pharmacol. 340, 135 (1989). LC-MS determn in plasma: J. Oxford, M. S. Lant, J. Chromatogr. 496, 137 (1989). Clinical evaluations in migraine: A. Doenicke et al., Lancet 1, 1309 (1988); Subcutaneous Sumatriptan International Study Group, N. Engl. J. Med. 325, 316 (1991); in acute cluster headache: Sumatriptan Cluster Headache Study Group, ibid. 322. Review of pharmacology and clinical experience: S. J. Peroutka, Headache 30 (Suppl. 2), 554-560 (1990).
Properties: mp 169-171°.
Melting point: mp 169-171°
Derivative Type: Succinate
CAS Registry Number: 103628-48-4
Manufacturers' Codes: GR-43175C
Trademarks: Imigran (GSK); Imitrex (GSK); Imiject (GSK)
Molecular Formula: C14H21N3O2S.C4H6O4
Molecular Weight: 413.49
Percent Composition: C 52.28%, H 6.58%, N 10.16%, O 23.22%, S 7.75%
Properties: mp 165-166°.
Melting point: mp 165-166°
Therap-Cat: Antimigraine.
Keywords: Antimigraine; Serotonin Receptor Agonist. |